Literature DB >> 16154245

Immunization with plasmid DNA encoding a truncated, secreted form of the bovine viral diarrhea virus E2 protein elicits strong humoral and cellular immune responses.

Rong Liang1, Jan V van den Hurk, Chunfu Zheng, Hong Yu, Reno A Pontarollo, Lorne A Babiuk, Sylvia van Drunen Littel-van den Hurk.   

Abstract

The major protective antigen of bovine viral diarrhea virus (BVDV), the E2 protein, is cell-associated and not expressed on the cell surface. In this study we evaluated a DNA vaccine encoding various secreted versions of E2. In vitro analysis demonstrated that deletion of the transmembrane anchor and addition of the signal sequence of bovine herpesvirus-1 (BHV-1) (gDsDeltaE2) resulted in efficient secretion of E2 into the culture medium. In contrast, full-length E2, either without or with gDs (gDsE2), as well as truncated E2 without gDs (DeltaE2), remained entirely cell-associated. Mice immunized with plasmid encoding gDsDeltaE2 developed significantly higher IgG and virus neutralizing antibody titres compared to animals vaccinated with plasmid encoding E2, DeltaE2 or gDsE2. To optimize secretion of E2, the efficiency of gDs was compared with that of the tissue plasminogen activator signal (tPAs) sequence. In addition, the effect of the plasmid backbone was assessed by comparing two vectors. Four plasmids, pMASIA-gDsDeltaE2, pMASIA-tPAsDeltaE2, pSLKIA-gDsDeltaE2 and pSLKIA-tPAsDeltaE2, were constructed and administered intradermally to mice. The mice immunized with pMASIA-tPAsDeltaE2 developed the strongest and most balanced immune responses. Vaccination of cattle confirmed that pMASIA-tPAsDeltaE2 elicited both strong humoral and cellular immune responses and thus could be a candidate DNA vaccine against BVDV.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16154245     DOI: 10.1016/j.vaccine.2005.06.025

Source DB:  PubMed          Journal:  Vaccine        ISSN: 0264-410X            Impact factor:   3.641


  6 in total

1.  Cellular targeting of engineered heterologous antigens is a determinant factor for bovine herpesvirus 4-based vaccine vector development.

Authors:  Gaetano Donofrio; Valentina Franceschi; Antonio Capocefalo; Simone Taddei; Chiara Sartori; Sabrina Bonomini; Sandro Cavirani; Clotilde S Cabassi; Cesidio F Flammini
Journal:  Clin Vaccine Immunol       Date:  2009-09-30

Review 2.  Bovine Pestivirus Heterogeneity and Its Potential Impact on Vaccination and Diagnosis.

Authors:  Victor Riitho; Rebecca Strong; Magdalena Larska; Simon P Graham; Falko Steinbach
Journal:  Viruses       Date:  2020-10-06       Impact factor: 5.048

3.  Enhancement of the expression of HCV core gene does not enhance core-specific immune response in DNA immunization: advantages of the heterologous DNA prime, protein boost immunization regimen.

Authors:  Ekaterina Alekseeva; Irina Sominskaya; Dace Skrastina; Irina Egorova; Elizaveta Starodubova; Eriks Kushners; Marija Mihailova; Natalia Petrakova; Ruta Bruvere; Tatyana Kozlovskaya; Maria Isaguliants; Paul Pumpens
Journal:  Genet Vaccines Ther       Date:  2009-06-08

4.  Establishment of a bovine herpesvirus 4 based vector expressing a secreted form of the bovine viral diarrhoea virus structural glycoprotein E2 for immunization purposes.

Authors:  Gaetano Donofrio; Chiara Sartori; Lara Ravanetti; Sandro Cavirani; Laurent Gillet; Alain Vanderplasschen; Simone Taddei; Cesidio Filippo Flammini
Journal:  BMC Biotechnol       Date:  2007-10-18       Impact factor: 2.563

5.  Immunization with Brugia malayi Myosin as Heterologous DNA Prime Protein Boost Induces Protective Immunity against B. malayi Infection in Mastomys coucha.

Authors:  Jyoti Gupta; Sweta Misra; Shailja Misra-Bhattacharya
Journal:  PLoS One       Date:  2016-11-09       Impact factor: 3.240

6.  Immunogenicity evaluation of recombinant Lactobacillus casei W56 expressing bovine viral diarrhea virus E2 protein in conjunction with cholera toxin B subunit as an adjuvant.

Authors:  Shuo Jia; Xinning Huang; Hua Li; Dianzhong Zheng; Li Wang; Xinyuan Qiao; Yanping Jiang; Wen Cui; Lijie Tang; Yijing Li; Yigang Xu
Journal:  Microb Cell Fact       Date:  2020-10-01       Impact factor: 6.352

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.